Premium
Treatment of Hepatitis C Infection in Renal Transplant Recipients: The Long Wait Is Over
Author(s) -
Saxena V.,
Terrault N. A.
Publication year - 2016
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.13697
Subject(s) - medicine , renal transplant , hepatitis c , intensive care medicine , gastroenterology , immunology , transplantation
With the availability of all‐oral direct antiviral drugs, safe and highly effective antivirals are now available to hepatitis C–infected kidney transplant recipients, and early single center experiences confirm excellent tolerability and high rates of viral eradication. See the articles by Kamar et al ( page 1474) and Sawinski et al ( page 1588).